Clinical ResearchHLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
Under a Creative Commons license
open archive
Key Words
Bone marrow transplantation
Cyclophosphamide
Histocompatibility antigens
Conditioning regimens
Leukemia
Lymphoma
Cited by (0)
- ∗
These authors contributed equally to this work.
Copyright © 2008 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.